CRISPR CLINICAL TRIALS
Medicine is changing.
New CRISPR gene editing clinical studies are rapidly emerging and we think a comprehensive overview is valuable to help keep track of them all.
CRISPR is the hot new rapidly rising gene editing tool but we also include clinical trials of other gene editing modalities like the Zinc Finger Nucleases, TALENs, MegaTALS, MegaNucleases and any new variants that will be out there in the future. We will keep updating our overview.
Check already now the world's-first clinical trial for a CRISPR-Cas3 phage therapy for treatment of urinary tract infections, developed by Locus BioSciences and get all the details about their unique technology from this interview with VP, Business Development, Joseph Nixon.
The clinical trials are arranged in the following areas: Antibacterials, Blood, Cancer, Eye and Metabolic disorders.
CRISPR-Cas | TALEN | ZFN | MegaNuclease | MegaTAL
Latest Trial News
Therapeutics
Antibacterial
Blood
Sponsors:
Affiliated Hospital to Academy of Military Medical Sciences
Sponsors:
Case Western Reserve University
Cancer
Sponsors:
Xijing Hospital, The Fourth Military Medical University
Sponsors:
Chinese PLA General Hospital
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
Sponsors:
Institut de Recherches Internationales Servier
Sponsors:
Institut de Recherches Internationales Servier
Sponsors:
Huazhong University of Science and Technology
Sponsors:
First Affiliated Hospital, Sun Yat-Sen University
Sponsors:
Huazhong University of Science and Technology
Sponsors:
Yang Yang, MD, PhD, MSCR, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sponsors:
CRISPR Therapeutics AG
Sponsors:
Great Ormond Street Hospital for Children NHS Trust
Eye
Metabolic Disorder
Other Genetic Conditions
Rare Diseases
Autoimmune Diseases
Diagnostics
Sponsors:
Huashan Hospital